Anne Altmeyer

Anne Altmeyer is a declared insider of Corbus Pharmaceuticals Holdings, Inc., with filings sourced from SEC (Form 4). The record holds 7 filings, for trades running from 30 May 2024 to 10 June 2026.

The open-market record consists of 3 sales worth €44k, with no purchase. Outside the open market, there are 3 share grants and 1 option exercise. In 2026 alone, the filings show no purchases and 1 sale.

On 11 June 2026 came the latest disclosure, an open-market sale for €17k in Corbus Pharmaceuticals Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.